期刊文献+

胸部非霍奇金淋巴瘤(弥漫大B细胞型)一例 被引量:1

原文传递
导出
摘要 患者,女,65岁,因"间断咳嗽、憋喘1个月"于2017年11月20日入院。患者间断感胸痛,无发热等其他不适。行胸部CT示(图1):⑴右下肺炎性病变,占位性质不排除;⑵右侧胸腔积液;⑶右肺门增大,占位性病变?遂入住本院呼吸科病房。入院后行肺部增强CT:⑴右肺门、右肺下叶近纵隔区及纵隔内软组织占位性病变,考虑恶性肿瘤,肺癌可能性大,并右肺阻塞性肺炎;⑵右肺中下叶炎症;⑶右侧胸腔积液并右肺下叶膨胀不全;⑷双侧胸膜增厚并右侧钙化;⑸心包少量积液。
出处 《中国医师杂志》 CAS 2019年第12期1908-1910,共3页 Journal of Chinese Physician
  • 相关文献

参考文献1

二级参考文献64

  • 1Friedberg JW,Byrtek M,Link BK,et al.Effectiveness of first-line management strategies for stage I follicular lymphoma:analysis of the National LymphoCare Study[J].J Clin Oncol,2012,30(27):3368-3375.
  • 2Michallet AS,Lebras LL,Bauwens DD,et al.Early stage follicular lymphoma:what is the clinical impact of the first-line treatment strategy?[J].J Hematol Oncol,2013,6:45.
  • 3Nastoupil L,Sinha R,Byrtek M,et al.A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma(FL)Used in the United States[J].ASH Annual Meeting Abstracts,2011,118:97.
  • 4Federico M,Luminari S,Dondi A,et al.R-CVP versus R- CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma:results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi[J],J Clin Oncol,2013,31(12):1506-1513.
  • 5Rummel MJ,Niederle N,Maschmeyer G,et al.Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas:an open-label,multicentre,randomised,phase 3 non-inferiority trial[J].Lancet,2013,381(9873):1203-1210.
  • 6Salles G,Seymour JF,Offner F,et al.Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy(PRIMA):a phase 3,randomised controlled trial[J]Lancet,2011,377(9759):42-51.
  • 7Rohatiner AZ,Gregory WM,Peterson B,et al.Meta-analysis to evaluate the role of interferon in follicular lymphoma[J].J Clin Oncol,2005,23(10):2215-2223.
  • 8Baldo P,Rupolo M,Compagnoni A,et al.Interferon-alpha for maintenance of follicular lymphoma[J],Cochrane Database Syst Rev,2010,20(1):CD004629.
  • 9Schaffel R,Hedvat CV,Teruya-Feldstein J,et al.Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma[J].Ann Oncol,2010,21(1):133-139.
  • 10Geisler CH,Kolstad A,Laurell A,et al.Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue:a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group[J].Blood,2008,112(7):2687-2693.

共引文献10

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部